| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1101040996 |
| P356 | DOI | 10.1186/S40659-018-0153-Z |
| P932 | PMC publication ID | 5815252 |
| P698 | PubMed publication ID | 29448959 |
| P50 | author | Michael Kremer | Q79788189 |
| P2093 | author name string | Ian N Hines | |
| Michael D Wheeler | |||
| Sherri M Moore | |||
| P2860 | cites work | Fatty acid-binding protein 5 limits the anti-inflammatory response in murine macrophages. | Q42183298 |
| Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis | Q43505905 | ||
| Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse lines | Q43701661 | ||
| Peroxisome proliferator-activated receptor alpha negatively regulates T-bet transcription through suppression of p38 mitogen-activated protein kinase activation | Q44484556 | ||
| Oxidized omega-3 fatty acids inhibit NF-kappaB activation via a PPARalpha-dependent pathway | Q44961833 | ||
| Peroxisome proliferator activated receptor-alpha expression in human liver. | Q46493867 | ||
| PPARalpha, but not PPARgamma, activators decrease macrophage-laden atherosclerotic lesions in a nondiabetic mouse model of mixed dyslipidemia | Q46580812 | ||
| IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1. | Q47216670 | ||
| IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners | Q47725575 | ||
| NKT cells: what's in a name? | Q47895830 | ||
| Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. | Q52551745 | ||
| Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis. | Q53411525 | ||
| Pivotal role of Smad3 in a mouse model of T cell-mediated hepatitis. | Q53515686 | ||
| Impaired liver regeneration and increased oval cell numbers following T cell-mediated hepatitis. | Q53544192 | ||
| Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice | Q73535883 | ||
| Contribution of Fas ligand to T cell-mediated hepatic injury in mice | Q73760660 | ||
| Alpha-glycosylceramides enhance the antitumor cytotoxicity of hepatic lymphocytes obtained from cancer patients by activating CD3-CD56+ NK cells in vitro | Q74027282 | ||
| Involvement of Fas/Fas ligand system-mediated apoptosis in the development of concanavalin A-induced hepatitis | Q77714954 | ||
| A key pathogenic role for the STAT1/T-bet signaling pathway in T-cell-mediated liver inflammation | Q79333114 | ||
| Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis | Q79788192 | ||
| Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators | Q24652367 | ||
| Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages | Q28283333 | ||
| Adaptive immune responses in acute and chronic hepatitis C virus infection | Q29619722 | ||
| PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophages | Q32033296 | ||
| PPARalpha activators inhibit tissue factor expression and activity in human monocytes | Q32033318 | ||
| CD69 and regulation of the immune function | Q33721814 | ||
| Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease. | Q33902002 | ||
| The molecular basis of T helper 1 and T helper 2 cell differentiation | Q34106569 | ||
| PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis | Q34509964 | ||
| T helper cell differentiation: on again, off again | Q34612549 | ||
| Lymphocyte recruitment to the liver in alcoholic liver disease. | Q34683358 | ||
| The peroxisome proliferator-activated receptor alpha (PPARalpha): role in hepatocarcinogenesis | Q34772498 | ||
| Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. | Q35150010 | ||
| A T cell-dependent experimental liver injury in mice inducible by concanavalin A | Q35603939 | ||
| Immune mechanisms of Concanavalin A model of autoimmune hepatitis | Q35670435 | ||
| Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver | Q35803521 | ||
| Importance of Kupffer cells for T-cell-dependent liver injury in mice | Q35829575 | ||
| To be or not to be NKT: natural killer T cells in the liver. | Q35919440 | ||
| Innate immunity in the liver | Q36036373 | ||
| T cell immunity in autoimmune hepatitis | Q36180095 | ||
| Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies | Q36870030 | ||
| Critical contribution of liver natural killer T cells to a murine model of hepatitis | Q36979591 | ||
| Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men. | Q37103503 | ||
| Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis | Q37144593 | ||
| Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage | Q38314701 | ||
| Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease | Q38320784 | ||
| Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system | Q38362320 | ||
| Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation | Q40560155 | ||
| Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease | Q40564278 | ||
| Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent | Q40765960 | ||
| A crucial role for T-bet in selectin ligand expression in T helper 1 (Th1) cells | Q42090258 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 5 | |
| P577 | publication date | 2018-02-15 | |
| P1433 | published in | Biological Research | Q2389484 |
| P1476 | title | Impaired T cell-mediated hepatitis in peroxisome proliferator activated receptor alpha (PPARα)-deficient mice | |
| P478 | volume | 51 |
Search more.